- Mallinckrodt plc stock price today and history
Mallinckrodt plc (MNK) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Mallinckrodt plc stock price
Mallinckrodt plc latest news:
Newell Brands, Mallinckrodt Stumble into Friday’s 52-Week Low Club
U.S. judge invalidates Mallinckrodt patents on respiratory treatment
Sept 5 (Reuters) - A federal court in Delaware on Tuesday
invalidated patents held by Mallinckrodt Pharmaceuticals
on its Inomax respiratory treatment system.
Mallinckrodt gets special FDA status for experimental muscular dystrophy drug
Mallinckrodt PLC shares rose in the extended session Wednesday after the drug maker said the Food and Drug Administration granted a special designation to one of its drugs intended to treat a rare form of muscular dystrophy. Mallinckrodt shares rose 1.8% to $44.90 after hours. The company said the FDA granted "orphan drug" status to its drug MNK-1411 for the treatment of Duchenne Muscular Dystrophy, or DMD. If the drug is approved, the status would give Mallinckrodt seven years of marketing exclusivity for the treatment as well as other perks like tax credits and waiver of some regulatory fees. The treatment is expected to enter mid-stage clinical trials later this year. DMD is a genetic form of muscular dystrophy that mostly affects young boys, where a certain protein that holds muscle cells together is absent. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Managed Duration Investment Grade Municipal FundMZF
Managed High Yield Plus FundHYF
Manchester United Ltd.MANU
Manning & NapierMN
Manulife Financial CorpMFC
Marathon Oil CorporationMRO
Marathon Petroleum CorporationMPC
Marcus & MillichapMMI